Stockreport

Reckitt deflects prospect of infant nutrition spin-off amid US litigation [Yahoo! Finance]

RECKITT BENCKISR GP S/ADR  (RBGLY) 
NASDAQ:AMEX Investor Relations: rb.com/investors
PDF Mead Johnson, which produces the Enfamil and Nutramigen formula brands, is facing the prospect of incurring as much as £2bn ($2.5bn) in damages related to the life-thre [Read more]